Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Capital Work in Progress

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Capital Work in Progress ₹294 Cr₹225 Cr₹137 Cr₹64 Cr₹130 Cr

What is the latest Capital Work in Progress ratio of NATCO PHARMA ?

The latest Capital Work in Progress ratio of NATCO PHARMA is ₹294 Cr based on Mar2026 Consolidated results.
Year Capital Work in Progress
Mar2026₹294 Cr
Mar2025₹225 Cr
Mar2024₹137 Cr
Mar2023₹64 Cr
Mar2022₹130 Cr

How is Capital Work in Progress of NATCO PHARMA Trending?

Years Capital Work in Progress % Change
Mar2026 ₹294 Cr
30.30
Mar2025 ₹225 Cr
64.17
Mar2024 ₹137 Cr
113.53
Mar2023 ₹64 Cr
-50.35
Mar2022 ₹130 Cr -

Compare Capital Work in Progress of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,831.3 Cr 1.6% -3.5% -2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,478.0 Cr -0.2% -3.2% 12.7% Stock Analytics
DIVIS LABORATORIES ₹253,031.0 Cr 2% 5.3% 57.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,216.0 Cr -2.4% -3.1% 36.4% Stock Analytics
CIPLA ₹112,205.0 Cr 0.6% -2.2% -9.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,040.0 Cr 0.9% 4% -7.6% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1.6%

-3.5%

-2.8%

SENSEX

-2.8%

-6.1%

-11.9%


You may also like the below Video Courses